ID   VMAT2_RAT               Reviewed;         515 AA.
AC   Q01827; Q9QVP1;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2003, sequence version 2.
DT   24-JUL-2024, entry version 163.
DE   RecName: Full=Synaptic vesicular amine transporter;
DE   AltName: Full=Monoamine transporter;
DE   AltName: Full=Solute carrier family 18 member 2;
DE   AltName: Full=Vesicular amine transporter 2;
DE            Short=VAT2;
GN   Name=Slc18a2; Synonyms=Svat {ECO:0000303|PubMed:8125935}, Vmat2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1505023; DOI=10.1016/0092-8674(92)90425-c;
RA   Liu Y., Peter D., Roghani A., Schuldiner S., Prive G.G., Eisenberg D.,
RA   Brecha N., Edwards R.H.;
RT   "A cDNA that suppresses MPP+ toxicity encodes a vesicular amine
RT   transporter.";
RL   Cell 70:539-551(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TRANSPORT ACTIVITY.
RX   PubMed=1438304; DOI=10.1073/pnas.89.22.10993;
RA   Erickson J.D., Eiden L.E., Hoffman B.J.;
RT   "Expression cloning of a reserpine-sensitive vesicular monoamine
RT   transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10993-10997(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Gastric corpus;
RX   PubMed=8745292; DOI=10.1113/jphysiol.1996.sp021140;
RA   Dimaline R., Struthers J.;
RT   "Expression and regulation of a vesicular monoamine transporter in rat
RT   stomach: a putative histamine transporter.";
RL   J. Physiol. (Lond.) 490:249-256(1996).
RN   [4]
RP   FUNCTION, TRANSPORT ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY
RP   REGULATION.
RX   PubMed=8125935; DOI=10.1016/s0021-9258(17)37272-1;
RA   Peter D., Jimenez J., Liu Y., Kim J., Edwards R.H.;
RT   "The chromaffin granule and synaptic vesicle amine transporters differ in
RT   substrate recognition and sensitivity to inhibitors.";
RL   J. Biol. Chem. 269:7231-7237(1994).
RN   [5]
RP   FUNCTION, TRANSPORT ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=8860238; DOI=10.1007/bf02736786;
RA   Erickson J.D., Eiden L.E., Schafer M.K., Weihe E.;
RT   "Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the
RT   neuronal isoform of the vesicular monoamine transporter.";
RL   J. Mol. Neurosci. 6:277-287(1995).
RN   [6]
RP   FUNCTION, TRANSPORT ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   180-SER--SER-182.
RX   PubMed=8606801; DOI=10.1016/0028-3908(95)00148-y;
RA   Merickel A., Edwards R.H.;
RT   "Transport of histamine by vesicular monoamine transporter-2.";
RL   Neuropharmacology 34:1543-1547(1995).
RN   [7]
RP   PHOSPHORYLATION AT SER-512 AND SER-514.
RX   PubMed=9045708; DOI=10.1074/jbc.272.10.6752;
RA   Krantz D.E., Peter D., Lui Y., Edwards R.H.;
RT   "Phosphorylation of a vesicular monoamine transporter by casein kinase
RT   II.";
RL   J. Biol. Chem. 272:6752-6759(1997).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-477;
RP   478-GLU-GLU-479; LYS-480; MET-481 AND 483-ILE-LEU-484.
RX   PubMed=16301178; DOI=10.1016/j.neuron.2005.09.033;
RA   Li H., Waites C.L., Staal R.G., Dobryy Y., Park J., Sulzer D.L.,
RA   Edwards R.H.;
RT   "Sorting of vesicular monoamine transporter 2 to the regulated secretory
RT   pathway confers the somatodendritic exocytosis of monoamines.";
RL   Neuron 48:619-633(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-512 AND SER-514, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   FUNCTION, TRANSPORT ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=25355561; DOI=10.1038/srep06836;
RA   Hiasa M., Miyaji T., Haruna Y., Takeuchi T., Harada Y., Moriyama S.,
RA   Yamamoto A., Omote H., Moriyama Y.;
RT   "Identification of a mammalian vesicular polyamine transporter.";
RL   Sci. Rep. 4:6836-6836(2014).
CC   -!- FUNCTION: Electrogenic antiporter that exchanges one cationic monoamine
CC       with two intravesicular protons across the membrane of secretory and
CC       synaptic vesicles. Uses the electrochemical proton gradient established
CC       by the V-type proton-pump ATPase to accumulate high concentrations of
CC       monoamines inside the vesicles prior to their release via exocytosis.
CC       Transports a variety of catecholamines such as dopamine, adrenaline and
CC       noradrenaline, histamine, and indolamines such as serotonin
CC       (PubMed:1438304, PubMed:25355561, PubMed:8125935, PubMed:8606801,
CC       PubMed:8860238). Regulates the transvesicular monoaminergic gradient
CC       that determines the quantal size. Mediates somatodendritic dopamine
CC       release in hippocampal neurons, likely as part of a regulated secretory
CC       pathway that integrates retrograde synaptic signals (PubMed:16301178).
CC       Acts as a primary transporter for striatal dopamine loading ensuring
CC       impulse-dependent release of dopamine at the synaptic cleft (By
CC       similarity). Responsible for histamine and serotonin storage and
CC       subsequent corelease from mast cell granules (By similarity)
CC       (PubMed:8860238). {ECO:0000250|UniProtKB:Q8BRU6,
CC       ECO:0000269|PubMed:1438304, ECO:0000269|PubMed:16301178,
CC       ECO:0000269|PubMed:8125935, ECO:0000269|PubMed:8606801,
CC       ECO:0000269|PubMed:8860238}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + serotonin(in) = 2 H(+)(in) + serotonin(out);
CC         Xref=Rhea:RHEA:73743, ChEBI:CHEBI:15378, ChEBI:CHEBI:350546;
CC         Evidence={ECO:0000269|PubMed:1438304, ECO:0000269|PubMed:25355561,
CC         ECO:0000269|PubMed:8125935};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:73744;
CC         Evidence={ECO:0000305|PubMed:8125935};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dopamine(in) + 2 H(+)(out) = dopamine(out) + 2 H(+)(in);
CC         Xref=Rhea:RHEA:73739, ChEBI:CHEBI:15378, ChEBI:CHEBI:59905;
CC         Evidence={ECO:0000269|PubMed:8125935};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:73740;
CC         Evidence={ECO:0000305|PubMed:8125935};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + histamine(in) = 2 H(+)(in) + histamine(out);
CC         Xref=Rhea:RHEA:73755, ChEBI:CHEBI:15378, ChEBI:CHEBI:58432;
CC         Evidence={ECO:0000269|PubMed:8606801, ECO:0000269|PubMed:8860238};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:73756;
CC         Evidence={ECO:0000305|PubMed:8606801};
CC   -!- ACTIVITY REGULATION: Inhibited by reserpine, ketanserin and
CC       tetrabenazine. Not significantly inhibited by vesamicol.
CC       {ECO:0000269|PubMed:25355561, ECO:0000269|PubMed:8125935,
CC       ECO:0000269|PubMed:8606801}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.19 uM for serotonin {ECO:0000269|PubMed:8125935};
CC   -!- SUBUNIT: Interacts with SLC6A3. {ECO:0000250|UniProtKB:Q8BRU6}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle membrane {ECO:0000269|PubMed:16301178}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000269|PubMed:16301178}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, axon {ECO:0000269|PubMed:16301178}.
CC       Cell projection, dendrite {ECO:0000269|PubMed:16301178}. Note=Sorted to
CC       large dense core granules in neuroendocrine cells, presumably at the
CC       level of the trans-Golgi network. In neurons it is predominantly
CC       detected in somatodendritic tubulovesicular membranes, a distinct
CC       population of secretory vesicles that undergo calcium-dependent
CC       exocytosis in axons and dendrites upon depolarization. Localized at
CC       synaptic vesicles in axons. {ECO:0000269|PubMed:16301178}.
CC   -!- TISSUE SPECIFICITY: Expressed in the substantia nigra and the
CC       tuberomammillary nucleus of the posterior hypothalamus
CC       (PubMed:8860238). Expressed in stomach, in particular in varicose nerve
CC       fibers and enterochromaffin-like cells in the corpus region (at protein
CC       level) (PubMed:8860238). {ECO:0000269|PubMed:8860238}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Vesicular
CC       transporter family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97381; AAA42190.1; -; mRNA.
DR   EMBL; L00603; AAA41627.1; -; mRNA.
DR   PIR; A46374; A46374.
DR   RefSeq; NP_037163.1; NM_013031.1.
DR   RefSeq; XP_006231726.1; XM_006231664.3.
DR   RefSeq; XP_017444313.1; XM_017588824.1.
DR   AlphaFoldDB; Q01827; -.
DR   SMR; Q01827; -.
DR   BioGRID; 247580; 2.
DR   CORUM; Q01827; -.
DR   STRING; 10116.ENSRNOP00000011983; -.
DR   BindingDB; Q01827; -.
DR   ChEMBL; CHEMBL4828; -.
DR   DrugCentral; Q01827; -.
DR   GuidetoPHARMACOLOGY; 1012; -.
DR   GlyCosmos; Q01827; 5 sites, No reported glycans.
DR   GlyGen; Q01827; 5 sites.
DR   iPTMnet; Q01827; -.
DR   PhosphoSitePlus; Q01827; -.
DR   PaxDb; 10116-ENSRNOP00000011983; -.
DR   ABCD; Q01827; 1 sequenced antibody.
DR   GeneID; 25549; -.
DR   KEGG; rno:25549; -.
DR   AGR; RGD:3694; -.
DR   CTD; 6571; -.
DR   RGD; 3694; Slc18a2.
DR   eggNOG; KOG3764; Eukaryota.
DR   InParanoid; Q01827; -.
DR   OrthoDB; 5388206at2759; -.
DR   PhylomeDB; Q01827; -.
DR   TreeFam; TF313494; -.
DR   Reactome; R-RNO-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   PRO; PR:Q01827; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0031045; C:dense core granule; IDA:RGD.
DR   GO; GO:0098691; C:dopaminergic synapse; IDA:SynGO.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0098992; C:neuronal dense core vesicle; IDA:SynGO.
DR   GO; GO:0099012; C:neuronal dense core vesicle membrane; IDA:SynGO.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0030667; C:secretory granule membrane; IDA:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005275; F:amine transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IPI:RGD.
DR   GO; GO:0015311; F:monoamine:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005335; F:serotonin:sodium:chloride symporter activity; IBA:GO_Central.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015842; P:aminergic neurotransmitter loading into synaptic vesicle; IMP:RGD.
DR   GO; GO:0071242; P:cellular response to ammonium ion; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0032456; P:endocytic recycling; IEP:RGD.
DR   GO; GO:0002553; P:histamine secretion by mast cell; ISO:RGD.
DR   GO; GO:0051615; P:histamine uptake; IDA:UniProtKB.
DR   GO; GO:0030073; P:insulin secretion; IDA:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0015844; P:monoamine transport; IDA:RGD.
DR   GO; GO:0051589; P:negative regulation of neurotransmitter transport; IMP:RGD.
DR   GO; GO:0098700; P:neurotransmitter loading into synaptic vesicle; ISO:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; IDA:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0009635; P:response to herbicide; IEP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0002552; P:serotonin secretion by mast cell; ISO:RGD.
DR   GO; GO:0051610; P:serotonin uptake; IDA:UniProtKB.
DR   GO; GO:0099123; P:somato-dendritic dopamine secretion; IDA:UniProtKB.
DR   CDD; cd17384; MFS_SLC18A1_2_VAT1_2; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 2.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR050930; MFS_Vesicular_Transporter.
DR   InterPro; IPR004734; Multidrug-R.
DR   NCBIfam; TIGR00880; 2_A_01_02; 1.
DR   PANTHER; PTHR23506; -; 1.
DR   PANTHER; PTHR23506:SF30; SYNAPTIC VESICULAR AMINE TRANSPORTER; 1.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Cytoplasmic vesicle; Disulfide bond; Glycoprotein;
KW   Membrane; Neurotransmitter transport; Phosphoprotein; Reference proteome;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..515
FT                   /note="Synaptic vesicular amine transporter"
FT                   /id="PRO_0000127516"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        21..41
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        42..130
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..151
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        152..160
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        161..181
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        182..190
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        191..211
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        212..220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        221..243
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        244..249
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        250..272
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        273..292
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        293..312
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        313..329
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        330..353
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        354..358
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        359..379
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        380..390
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..411
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        412..415
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        416..436
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        437..441
FT                   /note="Lumenal, vesicle"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        442..463
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        464..515
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         512
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:9045708,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         514
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:9045708,
FT                   ECO:0007744|PubMed:22673903"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        81
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        111
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        118..325
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         180..182
FT                   /note="SSS->AAA: Loss of activity. Abolishes histamine
FT                   uptake."
FT                   /evidence="ECO:0000269|PubMed:8606801"
FT   MUTAGEN         477
FT                   /note="K->A: Does not alter sorting to large dense
FT                   granules."
FT                   /evidence="ECO:0000269|PubMed:16301178"
FT   MUTAGEN         478..479
FT                   /note="EE->AA: Impairs sorting to large dense granules.
FT                   Delivered to the plasma membrane instead. Abolishes
FT                   exocytosis in dendrites. Reduces exocytosis in axons."
FT                   /evidence="ECO:0000269|PubMed:16301178"
FT   MUTAGEN         480
FT                   /note="K->A: Does not alter sorting to large dense
FT                   granules."
FT                   /evidence="ECO:0000269|PubMed:16301178"
FT   MUTAGEN         481
FT                   /note="M->A: Does not alter sorting to large dense
FT                   granules."
FT                   /evidence="ECO:0000269|PubMed:16301178"
FT   MUTAGEN         483..484
FT                   /note="IL->AA: Impairs sorting to large dense granules.
FT                   Delivered to the plasma membrane instead."
FT                   /evidence="ECO:0000269|PubMed:16301178"
FT   CONFLICT        220..221
FT                   /note="KP -> NA (in Ref. 2; AAA41627)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397
FT                   /note="G -> F (in Ref. 1; AAA42190)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        493
FT                   /note="R -> T (in Ref. 2; AAA41627)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   515 AA;  55690 MW;  627A904C1D35D552 CRC64;
     MALSDLVLLR WLRDSRHSRK LILFIVFLAL LLDNMLLTVV VPIIPSYLYS IKHEKNSTEI
     QTTRPELVVS TSESIFSYYN NSTVLITGNA TGTLPGGQSH KATSTQHTVA NTTVPSDCPS
     EDRDLLNENV QVGLLFASKA TVQLLTNPFI GLLTNRIGYP IPMFAGFCIM FISTVMFAFS
     SSYAFLLIAR SLQGIGSSCS SVAGMGMLAS VYTDDEERGK PMGIALGGLA MGVLVGPPFG
     SVLYEFVGKT APFLVLAALV LLDGAIQLFV LQPSRVQPES QKGTPLTTLL KDPYILIAAG
     SICFANMGIA MLEPALPIWM METMCSRKWQ LGVAFLPASI SYLIGTNIFG ILAHKMGRWL
     CALLGMVIVG ISILCIPFAK NIYGLIAPNF GVGFAIGMVD SSMMPIMGYL VDLRHVSVYG
     SVYAIADVAF CMGYAIGPSA GGAIAKAIGF PWLMTIIGII DIAFAPLCFF LRSPPAKEEK
     MAILMDHNCP IKRKMYTQNN VQSYPIGDDE ESESD
//
